Effects of Massage on the Immune System of Preterm Infants
Effects of Massage on Immune System of Preterm Infants
1 other identifier
interventional
120
1 country
1
Brief Summary
Infants in the Neonatal Intensive Care Unit (NICU) are exposed to stressful stimuli such as loud noises, bright lights, blood drawing, suctioning, and intubation, and are frequently left in isolation with minimal proper interaction. Stress has been demonstrated to exert a negative effect on the immune system. Different psychological interventions, including relaxation, have been used in efforts to reduce stress, and several of these techniques have been shown to improve cellular immunity. Massage therapy (MT) has been used to reduce stress in premature infants and has been associated with weight gain, shorter hospital stay, and improvement in mental/motor development. While MT has been shown to increase the number and function of natural killer (NK) cells in healthy adults and in adults infected with HIV, the effect of MT on the immune system of children, including premature infants, has never been investigated. The investigators hypothesize that, in premature infants, MT will enhance the immune system. One hundred and twenty stable premature infants meeting selection criteria will be randomized to massage and sham treatment groups. Immunologic evaluation will be performed on both groups at baseline, midway and at the end of therapy. Physicians, nurses, and parents will be masked. The investigators' unique and innovative study will be the largest study in this area and will provide valuable information on potential immune parameters associated with stress reduction and improved development in premature infants undergoing massage therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1
Started Oct 2005
Typical duration for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2005
CompletedFirst Submitted
Initial submission to the registry
April 20, 2006
CompletedFirst Posted
Study publicly available on registry
April 24, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2009
CompletedDecember 7, 2009
December 1, 2009
3.3 years
April 20, 2006
December 4, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
NK cell numbers
baseline, midway and end of study
Secondary Outcomes (1)
Cellular immune function
baseline, midway and end of study
Study Arms (2)
A,1
EXPERIMENTALMassage therapy
A,2
SHAM COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- Medically stable premature infants
You may not qualify if:
- Unstable premature infants with underlying medical condition
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Detroit Medical Center/Wayne State University
Detroit, Michigan, 48201, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jocelyn Y. Ang, MD
Wayne State University/Detroit Medical Center
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- NIH
Study Record Dates
First Submitted
April 20, 2006
First Posted
April 24, 2006
Study Start
October 1, 2005
Primary Completion
February 1, 2009
Study Completion
July 1, 2009
Last Updated
December 7, 2009
Record last verified: 2009-12